Build Your Comparison

Side-by-side financial analysis
FORA logo
FORA
INFU logo
INFU
BRT logo
BRT
HCSG logo
HCSG
NHI logo
NHI
JPM logo
JPM
Try popular comparisons:

Stock Comparison

FORA vs INFU vs BRT vs HCSG vs NHI vs JPM

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
FORA
Forian Inc.

Medical - Healthcare Information Services

HealthcareNASDAQ • US
Market Cap$68M
5Y Perf.-78.5%
INFU
InfuSystem Holdings, Inc.

Medical - Instruments & Supplies

HealthcareAMEX • US
Market Cap$190M
5Y Perf.-50.2%
BRT
BRT Apartments Corp.

REIT - Residential

Real EstateNYSE • US
Market Cap$280M
5Y Perf.-14.7%
HCSG
Healthcare Services Group, Inc.

Medical - Care Facilities

HealthcareNASDAQ • US
Market Cap$1.64B
5Y Perf.-23.6%
NHI
National Health Investors, Inc.

REIT - Healthcare Facilities

Real EstateNYSE • US
Market Cap$3.43B
5Y Perf.+6.4%
JPM
JPMorgan Chase & Co.

Banks - Diversified

Financial ServicesNYSE • US
Market Cap$908.57B
5Y Perf.+105.8%

FORA vs INFU vs BRT vs HCSG vs NHI vs JPM — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
FORA logoFORA
INFU logoINFU
BRT logoBRT
HCSG logoHCSG
NHI logoNHI
JPM logoJPM
IndustryMedical - Healthcare Information ServicesMedical - Instruments & SuppliesREIT - ResidentialMedical - Care FacilitiesREIT - Healthcare FacilitiesBanks - Diversified
Market Cap$68M$190M$280M$1.64B$3.43B$908.57B
Revenue (TTM)$30M$142M$98M$1.84B$403M$280.33B
Net Income (TTM)$-5M$8M$-12M$59M$148M$57.05B
Gross Margin46.8%56.7%41.5%13.3%61.3%60.0%
Operating Margin-13.4%9.1%12.4%3.0%48.5%25.9%
Forward P/E22.2x21.2x19.9x14.6x
Total Debt$12K$3M$508M$25M$1.16B$942.38B
Cash & Equiv.$13M$3M$25M$161M$20M$343.34B

FORA vs INFU vs BRT vs HCSG vs NHI vs JPMLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

FORA
INFU
BRT
HCSG
NHI
JPM
StockMar 21May 26Return
Forian Inc. (FORA)10021.5-78.5%
InfuSystem Holdings… (INFU)10049.8-50.2%
BRT Apartments Corp. (BRT)10085.3-14.7%
Healthcare Services… (HCSG)10076.4-23.6%
National Health Inv… (NHI)100106.4+6.4%
JPMorgan Chase & Co. (JPM)100205.8+105.8%

Price return only. Dividends and distributions are not included.

Quick Verdict: FORA vs INFU vs BRT vs HCSG vs NHI vs JPM

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: FORA leads in 2 of 7 categories (6-stock set), making it the strongest pick for growth and revenue expansion and capital preservation and lower volatility. InfuSystem Holdings, Inc. is the stronger pick specifically for operational efficiency and capital deployment. BRT, HCSG, NHI, and JPM also each lead in at least one category. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
🥇FORA emerged as the overall leader. Track its performance:
FORA
Forian Inc.
The Growth Play

FORA has the current edge in this matchup, primarily because of its strength in growth exposure and sleep-well-at-night.

  • Rev growth 50.1%, EPS growth 23.0%, 3Y rev CAGR 22.6%
  • Lower volatility, beta 0.21, Low D/E 0.0%, current ratio 2.97x
  • 50.1% revenue growth vs BRT's 1.5%
  • Beta 0.21 vs INFU's 1.22, lower leverage
Best for: growth exposure and sleep-well-at-night
INFU
InfuSystem Holdings, Inc.
The Niche Pick

INFU is the #2 pick in this set and the best alternative if efficiency is your priority.

  • 7.9% ROA vs FORA's -11.8%, ROIC 12.5% vs -7.5%
Best for: efficiency
BRT
BRT Apartments Corp.
The Real Estate Income Play

BRT ranks third and is worth considering specifically for income & stability and defensive.

  • Dividend streak 0 yrs, beta 0.45, yield 7.0%
  • Beta 0.45, yield 7.0%, current ratio 0.86x
  • 7.0% yield, vs JPM's 1.8%, (3 stocks pay no dividend)
Best for: income & stability and defensive
HCSG
Healthcare Services Group, Inc.
The Momentum Pick

HCSG is the clearest fit if your priority is momentum.

  • +58.9% vs BRT's -0.2%
Best for: momentum
NHI
National Health Investors, Inc.
The Real Estate Income Play

NHI is the clearest fit if your priority is quality.

  • 36.8% margin vs FORA's -17.0%
Best for: quality
JPM
JPMorgan Chase & Co.
The Banking Pick

JPM is the clearest fit if your priority is long-term compounding.

  • 481.2% 10Y total return vs BRT's 221.6%
  • Lower P/E (14.6x vs 19.9x)
Best for: long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthFORA logoFORA50.1% revenue growth vs BRT's 1.5%
ValueJPM logoJPMLower P/E (14.6x vs 19.9x)
Quality / MarginsNHI logoNHI36.8% margin vs FORA's -17.0%
Stability / SafetyFORA logoFORABeta 0.21 vs INFU's 1.22, lower leverage
DividendsBRT logoBRT7.0% yield, vs JPM's 1.8%, (3 stocks pay no dividend)
Momentum (1Y)HCSG logoHCSG+58.9% vs BRT's -0.2%
Efficiency (ROA)INFU logoINFU7.9% ROA vs FORA's -11.8%, ROIC 12.5% vs -7.5%

FORA vs INFU vs BRT vs HCSG vs NHI vs JPM — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

FORAForian Inc.
FY 2022
Information and Software
93.5%$26M
Service
5.5%$2M
Product and Service, Other
1.0%$274,256
INFUInfuSystem Holdings, Inc.
FY 2025
Patient Services
57.4%$87M
Device Solutions
42.6%$64M
BRTBRT Apartments Corp.
FY 2017
Multi Family Real Estate Segment
97.3%$103M
Other Real Estate Segment
2.7%$3M
HCSGHealthcare Services Group, Inc.
FY 2025
Dietary Services
55.1%$1.0B
Environmental Services
44.9%$825M
NHINational Health Investors, Inc.
FY 2025
Real Estate Investment Segment
78.7%$296M
Senior Housing Operating Portfolio
21.3%$80M
JPMJPMorgan Chase & Co.
FY 2025
Commercial And Investment Bank
43.0%$78.5B
Consumer & Community Banking
41.7%$76.0B
Asset and Wealth Management Segment
13.2%$24.1B
Segment Reporting, Reconciling Item, Corporate Nonsegment
3.9%$7.0B
Segment Reconciling Items
-1.7%$-3,134,000,000

FORA vs INFU vs BRT vs HCSG vs NHI vs JPM — Financial Metrics

Side-by-side numbers across 6 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLINFULAGGINGHCSG

Income & Cash Flow (Last 12 Months)

NHI leads this category, winning 5 of 6 comparable metrics.

JPM is the larger business by revenue, generating $280.3B annually — 9328.3x FORA's $30M. NHI is the more profitable business, keeping 36.8% of every revenue dollar as net income compared to FORA's -17.0%. On growth, NHI holds the edge at +29.7% YoY revenue growth, suggesting stronger near-term business momentum.

MetricFORA logoFORAForian Inc.INFU logoINFUInfuSystem Holdin…BRT logoBRTBRT Apartments Co…HCSG logoHCSGHealthcare Servic…NHI logoNHINational Health I…JPM logoJPMJPMorgan Chase & …
RevenueTrailing 12 months$30M$142M$98M$1.8B$403M$280.3B
EBITDAEarnings before interest/tax-$4M$26M$39M$72M$282M$81.4B
Net IncomeAfter-tax profit-$5M$8M-$12M$59M$148M$57.0B
Free Cash FlowCash after capex$2M$20M$12M$139M$226M$100.9B
Gross MarginGross profit ÷ Revenue+46.8%+56.7%+41.5%+13.3%+61.3%+60.0%
Operating MarginEBIT ÷ Revenue-13.4%+9.1%+12.4%+3.0%+48.5%+25.9%
Net MarginNet income ÷ Revenue-17.0%+5.6%-12.5%+3.2%+36.8%+20.4%
FCF MarginFCF ÷ Revenue+7.8%+14.3%+12.7%+7.6%+56.1%+36.0%
Rev. Growth (YoY)Latest quarter vs prior year-2.9%-3.0%+4.2%+6.6%+29.7%
EPS Growth (YoY)Latest quarter vs prior year-2.0%+5.9%-16.7%+175.0%+10.8%+16.0%
NHI leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

INFU leads this category, winning 2 of 6 comparable metrics.

At 16.2x trailing earnings, JPM trades at a 47% valuation discount to INFU's 30.4x P/E. On an enterprise value basis, INFU's 7.5x EV/EBITDA is more attractive than HCSG's 23.1x.

MetricFORA logoFORAForian Inc.INFU logoINFUInfuSystem Holdin…BRT logoBRTBRT Apartments Co…HCSG logoHCSGHealthcare Servic…NHI logoNHINational Health I…JPM logoJPMJPMorgan Chase & …
Market CapShares × price$68M$190M$280M$1.6B$3.4B$908.6B
Enterprise ValueMkt cap + debt − cash$55M$190M$763M$1.5B$4.6B$1.51T
Trailing P/EPrice ÷ TTM EPS-23.48x30.39x-22.56x28.32x23.45x16.22x
Forward P/EPrice ÷ next-FY EPS est.22.16x21.19x19.90x14.60x
PEG RatioP/E ÷ EPS growth rate0.92x
EV / EBITDAEnterprise value multiple7.55x20.41x23.07x16.42x18.52x
Price / SalesMarket cap ÷ Revenue2.24x1.33x2.89x0.89x9.07x3.25x
Price / BookPrice ÷ Book value/share2.27x3.47x1.51x3.28x2.16x2.51x
Price / FCFMarket cap ÷ FCF23.49x7.97x42.18x11.81x15.58x9.01x
INFU leads this category, winning 2 of 6 comparable metrics.

Profitability & Efficiency

INFU leads this category, winning 4 of 9 comparable metrics.

JPM delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $-17 for FORA. FORA carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to BRT's 2.87x. On the Piotroski fundamental quality scale (0–9), INFU scores 8/9 vs BRT's 3/9, reflecting strong financial health.

MetricFORA logoFORAForian Inc.INFU logoINFUInfuSystem Holdin…BRT logoBRTBRT Apartments Co…HCSG logoHCSGHealthcare Servic…NHI logoNHINational Health I…JPM logoJPMJPMorgan Chase & …
ROE (TTM)Return on equity-17.2%+14.0%-6.8%+11.8%+9.8%+15.9%
ROA (TTM)Return on assets-11.8%+7.9%-1.7%+7.3%+5.4%+1.3%
ROICReturn on invested capital-7.5%+12.5%+1.3%+9.0%+5.6%+4.5%
ROCEReturn on capital employed-8.2%+14.3%+1.6%+7.7%+8.0%+8.9%
Piotroski ScoreFundamental quality 0–9683765
Debt / EquityFinancial leverage0.00x0.06x2.87x0.05x0.76x2.60x
Net DebtTotal debt minus cash-$13M$241,000$483M-$136M$1.1B$599.0B
Cash & Equiv.Liquid assets$13M$3M$25M$161M$20M$343.3B
Total DebtShort + long-term debt$12,137$3M$508M$25M$1.2B$942.4B
Interest CoverageEBIT ÷ Interest expense-48.78x15.54x0.51x33.02x3.45x0.74x
INFU leads this category, winning 4 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

JPM leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in JPM five years ago would be worth $23,548 today (with dividends reinvested), compared to $1,735 for FORA. Over the past 12 months, HCSG leads with a +58.9% total return vs BRT's -0.2%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.7% vs BRT's -3.9% — a key indicator of consistent wealth creation.

MetricFORA logoFORAForian Inc.INFU logoINFUInfuSystem Holdin…BRT logoBRTBRT Apartments Co…HCSG logoHCSGHealthcare Servic…NHI logoNHINational Health I…JPM logoJPMJPMorgan Chase & …
YTD ReturnYear-to-date+2.4%+12.3%+4.7%+32.2%-6.6%+0.8%
1-Year ReturnPast 12 months+2.4%+52.2%-0.2%+58.9%+5.1%+20.9%
3-Year ReturnCumulative with dividends-7.3%-7.6%-11.2%+61.4%+52.9%+138.8%
5-Year ReturnCumulative with dividends-82.7%-50.2%+13.1%-23.2%+36.4%+135.5%
10-Year ReturnCumulative with dividends-90.5%+240.1%+221.6%-29.3%+53.0%+481.2%
CAGR (3Y)Annualised 3-year return-2.5%-2.6%-3.9%+17.3%+15.2%+33.7%
JPM leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — NHI and JPM each lead in 1 of 2 comparable metrics.

NHI is the less volatile stock with a -0.21 beta — it tends to amplify market swings less than INFU's 1.22 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. JPM currently trades 96.2% from its 52-week high vs NHI's 77.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricFORA logoFORAForian Inc.INFU logoINFUInfuSystem Holdin…BRT logoBRTBRT Apartments Co…HCSG logoHCSGHealthcare Servic…NHI logoNHINational Health I…JPM logoJPMJPMorgan Chase & …
Beta (5Y)Sensitivity to S&P 5000.21x1.22x0.45x1.08x-0.21x0.87x
52-Week HighHighest price in past year$2.71$11.04$16.69$24.39$90.94$338.09
52-Week LowLowest price in past year$1.64$5.38$13.18$12.66$67.94$269.72
% of 52W HighCurrent price vs 52-week peak+80.1%+85.3%+89.2%+94.1%+77.9%+96.2%
RSI (14)Momentum oscillator 0–10063.841.552.663.640.572.1
Avg Volume (50D)Average daily shares traded40K172K32K638K366K7.4M
Evenly matched — NHI and JPM each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — BRT and HCSG each lead in 1 of 2 comparable metrics.

Analyst consensus: INFU as "Buy", BRT as "Buy", HCSG as "Hold", NHI as "Hold", JPM as "Buy". Consensus price targets imply 59.2% upside for INFU (target: $15) vs 4.5% for JPM (target: $340). For income investors, BRT offers the higher dividend yield at 7.05% vs JPM's 1.83%.

MetricFORA logoFORAForian Inc.INFU logoINFUInfuSystem Holdin…BRT logoBRTBRT Apartments Co…HCSG logoHCSGHealthcare Servic…NHI logoNHINational Health I…JPM logoJPMJPMorgan Chase & …
Analyst RatingConsensus buy/hold/sellBuyBuyHoldHoldBuy
Price TargetConsensus 12-month target$15.00$21.00$24.50$83.40$339.75
# AnalystsCovering analysts35151861
Dividend YieldAnnual dividend ÷ price+7.0%+5.1%+1.8%
Dividend StreakConsecutive years of raises019115
Dividend / ShareAnnual DPS$1.05$3.61$5.95
Buyback YieldShare repurchases ÷ mkt cap+0.6%+5.8%+1.8%+3.7%0.0%+3.8%
Evenly matched — BRT and HCSG each lead in 1 of 2 comparable metrics.
Key Takeaway

INFU leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). NHI leads in 1 (Income & Cash Flow). 2 tied.

Best OverallInfuSystem Holdings, Inc. (INFU)Leads 2 of 6 categories
Loading custom metrics...

FORA vs INFU vs BRT vs HCSG vs NHI vs JPM: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is FORA or INFU or BRT or HCSG or NHI or JPM a better buy right now?

For growth investors, Forian Inc.

(FORA) is the stronger pick with 50. 1% revenue growth year-over-year, versus 1. 5% for BRT Apartments Corp. (BRT). JPMorgan Chase & Co. (JPM) offers the better valuation at 16. 2x trailing P/E (14. 6x forward), making it the more compelling value choice. Analysts rate InfuSystem Holdings, Inc. (INFU) a "Buy" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — FORA or INFU or BRT or HCSG or NHI or JPM?

On trailing P/E, JPMorgan Chase & Co.

(JPM) is the cheapest at 16. 2x versus InfuSystem Holdings, Inc. at 30. 4x. On forward P/E, JPMorgan Chase & Co. is actually cheaper at 14. 6x.

03

Which is the better long-term investment — FORA or INFU or BRT or HCSG or NHI or JPM?

Over the past 5 years, JPMorgan Chase & Co.

(JPM) delivered a total return of +135. 5%, compared to -82. 7% for Forian Inc. (FORA). Over 10 years, the gap is even starker: JPM returned +481. 2% versus FORA's -90. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — FORA or INFU or BRT or HCSG or NHI or JPM?

By beta (market sensitivity over 5 years), National Health Investors, Inc.

(NHI) is the lower-risk stock at -0. 21β versus InfuSystem Holdings, Inc. 's 1. 22β — meaning INFU is approximately -678% more volatile than NHI relative to the S&P 500. On balance sheet safety, Forian Inc. (FORA) carries a lower debt/equity ratio of 0% versus 3% for BRT Apartments Corp. — giving it more financial flexibility in a downturn.

05

Which is growing faster — FORA or INFU or BRT or HCSG or NHI or JPM?

By revenue growth (latest reported year), Forian Inc.

(FORA) is pulling ahead at 50. 1% versus 1. 5% for BRT Apartments Corp. (BRT). On earnings-per-share growth, the picture is similar: InfuSystem Holdings, Inc. grew EPS 181. 8% year-over-year, compared to -26. 9% for BRT Apartments Corp.. Over a 3-year CAGR, FORA leads at 22. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — FORA or INFU or BRT or HCSG or NHI or JPM?

National Health Investors, Inc.

(NHI) is the more profitable company, earning 37. 6% net margin versus -12. 3% for BRT Apartments Corp. — meaning it keeps 37. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NHI leads at 51. 5% versus -8. 2% for FORA. At the gross margin level — before operating expenses — JPM leads at 59. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is FORA or INFU or BRT or HCSG or NHI or JPM more undervalued right now?

On forward earnings alone, JPMorgan Chase & Co.

(JPM) trades at 14. 6x forward P/E versus 22. 2x for InfuSystem Holdings, Inc. — 7. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for INFU: 59. 2% to $15. 00.

08

Which pays a better dividend — FORA or INFU or BRT or HCSG or NHI or JPM?

In this comparison, BRT (7.

0% yield), NHI (5. 1% yield), JPM (1. 8% yield) pay a dividend. FORA, INFU, HCSG do not pay a meaningful dividend and should not be held primarily for income.

09

Is FORA or INFU or BRT or HCSG or NHI or JPM better for a retirement portfolio?

For long-horizon retirement investors, National Health Investors, Inc.

(NHI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 21), 5. 1% yield). Both have compounded well over 10 years (NHI: +53. 0%, HCSG: -29. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between FORA and INFU and BRT and HCSG and NHI and JPM?

These companies operate in different sectors (FORA (Healthcare) and INFU (Healthcare) and BRT (Real Estate) and HCSG (Healthcare) and NHI (Real Estate) and JPM (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: FORA is a small-cap high-growth stock; INFU is a small-cap quality compounder stock; BRT is a small-cap income-oriented stock; HCSG is a small-cap quality compounder stock; NHI is a small-cap income-oriented stock; JPM is a large-cap deep-value stock. BRT, NHI, JPM pay a dividend while FORA, INFU, HCSG do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.